{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T23:41:14Z","timestamp":1767310874845,"version":"3.48.0"},"publisher-location":"Cham","reference-count":82,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032076854","type":"print"},{"value":"9783032076861","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-07686-1_12","type":"book-chapter","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T23:38:38Z","timestamp":1767310718000},"page":"251-273","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic Liver Allograft Rejection: Histopathological Insights and Future Directions"],"prefix":"10.1007","author":[{"given":"Samar","family":"Seeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adib","family":"Edilbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashton A.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhna","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"10","key":"12_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1097\/PAS.0b013e31817a8e96","volume":"32","author":"SC Abraham","year":"2008","unstructured":"Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu T-T (2008) Significance of central perivenulitis in pediatric liver transplantation. Am J Surg Pathol 32(10):1479\u20131488. https:\/\/doi.org\/10.1097\/PAS.0b013e31817a8e96","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"12_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1084\/jem.189.2.441","volume":"189","author":"SC Afford","year":"1999","unstructured":"Afford SC, Randhawa S, Eliopoulos AG, Hubscher SG, Young LS, Adams DH (1999) CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface fas ligand expression and amplifies fas-mediated hepatocyte death during allograft rejection. J Exp Med 189(2):441\u2013446. https:\/\/doi.org\/10.1084\/jem.189.2.441","journal-title":"J Exp Med"},{"issue":"7","key":"12_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/lt.22302","volume":"17","author":"I Aguilera","year":"2011","unstructured":"Aguilera I, Sousa JM, Gavilan F, Gomez L, Alvarez-M\u00e1rquez A, N\u00fa\u00f1ez-Rold\u00e1n A (2011) Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transpl 17(7):779\u2013788. https:\/\/doi.org\/10.1002\/lt.22302","journal-title":"Liver Transpl"},{"issue":"29","key":"12_CR4","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.3748\/wjg.v24.i29.3239","volume":"24","author":"I Aguilera","year":"2018","unstructured":"Aguilera I, Aguado-Dominguez E, Sousa JM, Nu\u00f1ez-Roldan A (2018) Rethinking de novo immune hepatitis, an old concept for liver allograft rejection: relevance of glutathione S-transferase T1 mismatch. World J Gastroenterol 24(29):3239\u20133249. https:\/\/doi.org\/10.3748\/wjg.v24.i29.3239","journal-title":"World J Gastroenterol"},{"issue":"45","key":"12_CR5","doi-asserted-by":"publisher","first-page":"7771","DOI":"10.3748\/wjg.v27.i45.7771","volume":"27","author":"R Angelico","year":"2021","unstructured":"Angelico R, Sensi B, Manzia TM, Tisone G, Grassi G, Signorello A, Milana M, Lenci I, Baiocchi L (2021) Chronic rejection after liver transplantation: opening the Pandora\u2019s box. World J Gastroenterol 27(45):7771\u20137783. https:\/\/doi.org\/10.3748\/wjg.v27.i45.7771","journal-title":"World J Gastroenterol"},{"issue":"4","key":"12_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152833","volume":"216","author":"N Bakshi","year":"2020","unstructured":"Bakshi N, Gulati N, Rastogi A, Chougule A, Bihari C, Jindal A (2020) Nodular regenerative hyperplasia\u2014an under-recognized vascular disorder of liver. Pathol Res Pract 216(4):152833. https:\/\/doi.org\/10.1016\/j.prp.2020.152833","journal-title":"Pathol Res Pract"},{"issue":"10","key":"12_CR7","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/lt.23481","volume":"18","author":"Banff Working Group on Liver Allograft Pathology","year":"2012","unstructured":"Banff Working Group on Liver Allograft Pathology (2012) Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance. Liver Transpl 18(10):1154\u20131170. https:\/\/doi.org\/10.1002\/lt.23481","journal-title":"Liver Transpl"},{"issue":"2","key":"12_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/hep.21280","volume":"44","author":"AJ Demetris","year":"2006","unstructured":"Banff Working Group, Demetris AJ, Adeyi O, Bellamy COC, Clouston A, Charlotte F, Czaja A, Daskal I, El-Monayeri MS, Fontes P, Fung J, Gridelli B, Guido M, Haga H, Hart J, Honsova E, Hubscher S, Itoh T, Jhala N et al (2006) Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology 44(2):489\u2013501. https:\/\/doi.org\/10.1002\/hep.21280","journal-title":"Hepatology"},{"issue":"12","key":"12_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/lt.26479","volume":"28","author":"AK Baumann","year":"2022","unstructured":"Baumann AK, Beck J, Kirchner T, Hartleben B, Sch\u00fctz E, Oellerich M, Wedemeyer H, Jaeckel E, Taubert R (2022) Elevated fractional donor-derived cell-free DNA during subclinical graft injury after liver transplantation. Liver Transpl 28(12):1911\u20131919. https:\/\/doi.org\/10.1002\/lt.26479","journal-title":"Liver Transpl"},{"issue":"6","key":"12_CR10","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ajt.2024.03.008","volume":"24","author":"COC Bellamy","year":"2024","unstructured":"Bellamy COC, O\u2019Leary JG, Adeyi O, Baddour N, Batal I, Bucuvalas J, Del Bello A, El Hag M, El-Monayeri M, Farris AB, Feng S, Fiel MI, Fischer SE, Fung J, Grzyb K, Guimei M, Haga H, Hart J, Jackson AM et al (2024) Banff 2022 Liver Group Meeting report: monitoring long-term allograft health. Am J Transplant 24(6):905\u2013917. https:\/\/doi.org\/10.1016\/j.ajt.2024.03.008","journal-title":"Am J Transplant"},{"key":"12_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/frtra.2023.1221765","volume":"2","author":"BE Biesterveld","year":"2023","unstructured":"Biesterveld BE, Schroder PM, Hitchcock ME, Bolognese A, Kim SC, Al-Adra DP (2023) Nodular regenerative hyperplasia and liver transplantation: a systematic review. Front Transplant 2:1221765. https:\/\/doi.org\/10.3389\/frtra.2023.1221765","journal-title":"Front Transplant"},{"issue":"4","key":"12_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jceh.2017.10.003","volume":"7","author":"NS Choudhary","year":"2017","unstructured":"Choudhary NS, Saigal S, Bansal RK, Saraf N, Gautam D, Soin AS (2017) Acute and chronic rejection after liver transplantation: what a clinician needs to know. J Clin Exp Hepatol 7(4):358\u2013366. https:\/\/doi.org\/10.1016\/j.jceh.2017.10.003","journal-title":"J Clin Exp Hepatol"},{"issue":"3","key":"12_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/bjsopen\/zraf034","volume":"9","author":"BVM Dasari","year":"2025","unstructured":"Dasari BVM, Line P-D, Sapisochin G, Hibi T, Bhangui P, Halazun KJ, Shetty S, Shah T, Magyar CTJ, Donnelly C, Chatterjee D (2025) Liver transplantation as a treatment for cancer: comprehensive review. BJS Open 9(3):zraf034. https:\/\/doi.org\/10.1093\/bjsopen\/zraf034","journal-title":"BJS Open"},{"issue":"1","key":"12_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/lt.500060106","volume":"6","author":"AJ Demetris","year":"2000","unstructured":"Demetris AJ (2000) Spectrum of chronic hepatic allograft rejection and arteriopathy and the controversy of centrilobular necrosis. Liver Transpl 6(1):102\u2013103. https:\/\/doi.org\/10.1002\/lt.500060106","journal-title":"Liver Transpl"},{"issue":"2","key":"12_CR15","first-page":"27","volume":"2","author":"AJ Demetris","year":"1997","unstructured":"Demetris AJ, Murase N, Lee RG, Randhawa P, Zeevi A, Pham S, Duquesnoy R, Fung JJ, Starzl TE (1997) Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts. Ann Transplant 2(2):27\u201344","journal-title":"Ann Transplant"},{"issue":"2","key":"12_CR16","first-page":"52","volume":"1","author":"AJ Demetris","year":"1998","unstructured":"Demetris AJ, Murase N, Starzl TE, Fung JJ (1998) Pathology of chronic rejection: an overview of common findings and observations about pathogenic mechanisms and possible prevention. Graft (Georgetown, Tex) 1(2):52\u201359","journal-title":"Graft (Georgetown, Tex)"},{"issue":"3","key":"12_CR17","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.510310337","volume":"31","author":"A Demetris","year":"2000","unstructured":"Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, Fung J, Gouw A, Gustafsson B, Haga H, Harrison D, Hart J, Hubscher S, Jaffe R, Khettry U, Lassman C, Lewin K, Martinez O, Nakazawa Y et al (2000) Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology 31(3):792\u2013799. https:\/\/doi.org\/10.1002\/hep.510310337","journal-title":"Hepatology"},{"issue":"10","key":"12_CR18","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1111\/ajt.13909","volume":"16","author":"AJ Demetris","year":"2016","unstructured":"Demetris AJ, Bellamy C, H\u00fcbscher SG, O\u2019Leary J, Randhawa PS, Feng S, Neil D, Colvin RB, McCaughan G, Fung JJ, Del Bello A, Reinholt FP, Haga H, Adeyi O, Czaja AJ, Schiano T, Fiel MI, Smith ML, Sebagh M et al (2016) 2016 Comprehensive Update of the Banff Working Group on liver allograft pathology: introduction of antibody-mediated rejection. Am J Transplant 16(10):2816\u20132835. https:\/\/doi.org\/10.1111\/ajt.13909","journal-title":"Am J Transplant"},{"issue":"12","key":"12_CR19","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1097\/00007890-199612270-00016","volume":"62","author":"G Demirci","year":"1996","unstructured":"Demirci G, Nashan B, Pichlmayr R (1996) Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3. Transplantation 62(12):1776\u20131783. https:\/\/doi.org\/10.1097\/00007890-199612270-00016","journal-title":"Transplantation"},{"key":"12_CR20","doi-asserted-by":"publisher","unstructured":"Engel B, Alaswad A, Campos-Murguia A, Zoodsma M, Klingbeil A, Ruiz P, Crespo G, Chihab K, Bosselmann EA, Heinrich S, Hartleben B, Jonigk DD, Diaz A, Verboom M, Hallensleben M, Geffers R, Falk CS, Ruff S, Lauber C et al (2025) Molecular signatures discriminating different types of rejection in human liver transplants. J Hepatol. S0168-8278(25)02338-4. https:\/\/doi.org\/10.1016\/j.jhep.2025.06.036","DOI":"10.1016\/j.jhep.2025.06.036"},{"issue":"5","key":"12_CR21","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/hep.21152","volume":"43","author":"HM Evans","year":"2006","unstructured":"Evans HM, Kelly DA, McKiernan PJ, H\u00fcbscher S (2006) Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 43(5):1109\u20131117. https:\/\/doi.org\/10.1002\/hep.21152","journal-title":"Hepatology"},{"issue":"5","key":"12_CR22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/00063030-200014050-00002","volume":"14","author":"RF Garcia","year":"2000","unstructured":"Garcia RF, Garcia CE, McMaster P (2000) Chronic rejection of the liver: the role of immunosuppression. BioDrugs 14(5):283\u2013297. https:\/\/doi.org\/10.2165\/00063030-200014050-00002","journal-title":"BioDrugs"},{"issue":"5","key":"12_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13471","volume":"23","author":"I Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez I, Lu H-C, Ritter JH, Maluf HM, Dehner LP, He M (2019) Clinicopathologic characteristics of de novo nodular regenerative hyperplasia in pediatric liver transplant. Pediatr Transplant 23(5):e13471. https:\/\/doi.org\/10.1111\/petr.13471","journal-title":"Pediatr Transplant"},{"issue":"2","key":"12_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/ajt.12590","volume":"14","author":"M Haas","year":"2014","unstructured":"Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, Cendales LC, Cornell LD, Demetris AJ, Drachenberg CB, Farver CF, Farris AB 3rd, Gibson IW, Kraus E, Liapis H et al (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant 14(2):272\u2013283. https:\/\/doi.org\/10.1111\/ajt.12590","journal-title":"Am J Transplant"},{"issue":"2","key":"12_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","volume":"18","author":"M Haas","year":"2018","unstructured":"Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, Duong Van Huyen JP, Gibson IW, Kraus ES, Mannon RB et al (2018) The Banff 2017 Kidney Meeting Report: revised diagnostic criteria for chronic active T cell\u2013mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 18(2):293\u2013307. https:\/\/doi.org\/10.1111\/ajt.14625","journal-title":"Am J Transplant"},{"issue":"12","key":"12_CR26","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1097\/00007890-199560120-00027","volume":"60","author":"M Hayashi","year":"1995","unstructured":"Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60(12):1533\u20131538. https:\/\/doi.org\/10.1097\/00007890-199560120-00027","journal-title":"Transplantation"},{"issue":"7","key":"12_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/lt.21444","volume":"14","author":"D Herzog","year":"2008","unstructured":"Herzog D, Soglio DB-D, Fournet J-C, Martin S, Marleau D, Alvarez F (2008) Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl 14(7):946\u2013955. https:\/\/doi.org\/10.1002\/lt.21444","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"12_CR28","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1002\/lt.21902","volume":"15","author":"S H\u00fcbscher","year":"2009","unstructured":"H\u00fcbscher S (2009) What does the long-term liver allograft look like for the pediatric recipient? Liver Transpl 15(Suppl 2):S19\u2013S24. https:\/\/doi.org\/10.1002\/lt.21902","journal-title":"Liver Transpl"},{"issue":"5","key":"12_CR29","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/00007890-199105000-00014","volume":"51","author":"SG Hubscher","year":"1991","unstructured":"Hubscher SG, Buckels JA, Elias E, McMaster P, Neuberger J (1991) Vanishing bile-duct syndrome following liver transplantation\u2014is it reversible? Transplantation 51(5):1004\u20131010. https:\/\/doi.org\/10.1097\/00007890-199105000-00014","journal-title":"Transplantation"},{"issue":"6","key":"12_CR30","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.hpb.2020.10.002","volume":"23","author":"C Kaltenmeier","year":"2021","unstructured":"Kaltenmeier C, Jorgensen D, Dharmayan S, Ayloo S, Rachakonda V, Geller DA, Tohme S, Molinari M (2021) The liver transplant risk score prognosticates the outcomes of liver transplant recipients at listing. HPB (Oxford) 23(6):927\u2013936. https:\/\/doi.org\/10.1016\/j.hpb.2020.10.002","journal-title":"HPB (Oxford)"},{"issue":"11","key":"12_CR31","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/lt.24616","volume":"22","author":"D Kelly","year":"2016","unstructured":"Kelly D, Verkade HJ, Rajanayagam J, McKiernan P, Mazariegos G, H\u00fcbscher S (2016) Late graft hepatitis and fibrosis in pediatric liver allograft recipients: current concepts and future developments. Liver Transpl 22(11):1593\u20131602. https:\/\/doi.org\/10.1002\/lt.24616","journal-title":"Liver Transpl"},{"issue":"9100","key":"12_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","volume":"351","author":"N Kerkar","year":"1998","unstructured":"Kerkar N, Hadzi\u0107 N, Davies ET, Portmann B, Donaldson PT, Rela M, Heaton ND, Vergani D, Mieli-Vergani G (1998) De-novo autoimmune hepatitis after liver transplantation. Lancet (London, England) 351(9100):409\u2013413. https:\/\/doi.org\/10.1016\/S0140-6736(97)06478-7","journal-title":"Lancet (London, England)"},{"issue":"5","key":"12_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/lt.21404","volume":"14","author":"AM Krasinskas","year":"2008","unstructured":"Krasinskas AM, Demetris AJ, Poterucha JJ, Abraham SC (2008) The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Liver Transpl 14(5):625\u2013632. https:\/\/doi.org\/10.1002\/lt.21404","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"12_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/ajt.16978","volume":"22","author":"AJ Kwong","year":"2022","unstructured":"Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Foutz J, Gauntt K, Cafarella M, Snyder JJ, Israni AK, Kasiske BL (2022) OPTN\/SRTR 2020 Annual data report: liver. Am J Transplant 22(Suppl 2):204\u2013309. https:\/\/doi.org\/10.1111\/ajt.16978","journal-title":"Am J Transplant"},{"key":"12_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humpath.2023.02.005","volume":"135","author":"NB Leonard","year":"2023","unstructured":"Leonard NB, Hale GL, Boylan KE, Ou Z, Zhang C, Kim R, Chandna S, Dong ZM, Evason KJ (2023) Histologic features of allograft livers in patients treated for rejection before biopsy. Hum Pathol 135:11\u201321. https:\/\/doi.org\/10.1016\/j.humpath.2023.02.005","journal-title":"Hum Pathol"},{"issue":"2","key":"12_CR36","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/ajt.16835","volume":"22","author":"J Levitsky","year":"2022","unstructured":"Levitsky J, Kandpal M, Guo K, Kleiboeker S, Sinha R, Abecassis M (2022) Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients. Am J Transplant 22(2):532\u2013540. https:\/\/doi.org\/10.1111\/ajt.16835","journal-title":"Am J Transplant"},{"issue":"3","key":"12_CR37","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jhep.2018.04.012","volume":"69","author":"M-C Londo\u00f1o","year":"2018","unstructured":"Londo\u00f1o M-C, Souza LN, Lozano J-J, Miquel R, Abraldes JG, Llovet L-P, Quaglia A, Rimola A, Navasa M, S\u00e1nchez-Fueyo A (2018) Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients. J Hepatol 69(3):626\u2013634. https:\/\/doi.org\/10.1016\/j.jhep.2018.04.012","journal-title":"J Hepatol"},{"issue":"3","key":"12_CR38","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/lt.20094","volume":"10","author":"MO Lovell","year":"2004","unstructured":"Lovell MO, Speeg KV, Halff GA, Molina DK, Sharkey FE (2004) Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode. Liver Transpl 10(3):369\u2013373. https:\/\/doi.org\/10.1002\/lt.20094","journal-title":"Liver Transpl"},{"issue":"1","key":"12_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/lt.23566","volume":"19","author":"MR Lucey","year":"2013","unstructured":"Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW (2013) Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl 19(1):3\u201326. https:\/\/doi.org\/10.1002\/lt.23566","journal-title":"Liver Transpl"},{"issue":"6","key":"12_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/s0025-6196(12)65347-6","volume":"64","author":"J Ludwig","year":"1989","unstructured":"Ludwig J (1989) Classification and terminology of hepatic allograft rejection: whither bound? Mayo Clin Proc 64(6):676\u2013679. https:\/\/doi.org\/10.1016\/s0025-6196(12)65347-6","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"12_CR41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0002-9440(10)64089-8","volume":"158","author":"JG Lunz 3rd","year":"2001","unstructured":"Lunz JG 3rd, Contrucci S, Ruppert K, Murase N, Fung JJ, Starzl TE, Demetris AJ (2001) Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1\/Cip1) as a disease marker and the influence of immunosuppressive drugs. Am J Pathol 158(4):1379\u20131390. https:\/\/doi.org\/10.1016\/S0002-9440(10)64089-8","journal-title":"Am J Pathol"},{"issue":"8","key":"12_CR42","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1111\/ajt.15828","volume":"20","author":"K Madill-Thomsen","year":"2020","unstructured":"Madill-Thomsen K, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Gr\u0105t M, Jurczyk K, Klintmalm G, Krasnod\u0119bski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, My\u015blak M, P\u0105czek L et al (2020) The molecular diagnosis of rejection in liver transplant biopsies: first results of the INTERLIVER study. Am J Transplant 20(8):2156\u20132172. https:\/\/doi.org\/10.1111\/ajt.15828","journal-title":"Am J Transplant"},{"issue":"3","key":"12_CR43","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/ajt.16890","volume":"22","author":"KS Madill-Thomsen","year":"2022","unstructured":"Madill-Thomsen KS, Abouljoud M, Bhati C, Ciszek M, Durlik M, Feng S, Foroncewicz B, Francis I, Gr\u0105t M, Jurczyk K, Klintmalm G, Krasnod\u0119bski M, McCaughan G, Miquel R, Montano-Loza A, Moonka D, Mucha K, My\u015blak M, P\u0105czek L et al (2022) The molecular phenotypes of injury, steatohepatitis, and fibrosis in liver transplant biopsies in the INTERLIVER study. Am J Transplant 22(3):909\u2013926. https:\/\/doi.org\/10.1111\/ajt.16890","journal-title":"Am J Transplant"},{"issue":"8","key":"12_CR44","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/TP.0000000000005269","volume":"109","author":"KS Madill-Thomsen","year":"2025","unstructured":"Madill-Thomsen KS, Gauthier PT, Abouljoud M, Bhati C, Bruno D, Ciszek M, Durlik M, Feng S, Foroncewicz B, Gr\u0105t M, Jurczyk K, Levitsky J, McCaughan G, Maluf D, Montano-Loza A, Moonka D, Mucha K, My\u015blak M, Perkowska-Ptasi\u0144ska A et al (2025) Defining an NK cell-enriched rejection-like phenotype in liver transplant biopsies from the INTERLIVER study. Transplantation 109(8):1367\u20131382. https:\/\/doi.org\/10.1097\/TP.0000000000005269","journal-title":"Transplantation"},{"issue":"2","key":"12_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00007890-200007270-00009","volume":"70","author":"Y Maor-Kendler","year":"2000","unstructured":"Maor-Kendler Y, Batts KP, Burgart LJ, Wiesner RH, Krom RA, Rosen CB, Charlton MR (2000) Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. Transplantation 70(2):292\u2013297. https:\/\/doi.org\/10.1097\/00007890-200007270-00009","journal-title":"Transplantation"},{"issue":"7","key":"12_CR46","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","volume":"6","author":"VC McAlister","year":"2006","unstructured":"McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL (2006) Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 6(7):1578\u20131585. https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01360.x","journal-title":"Am J Transplant"},{"issue":"6","key":"12_CR47","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/hep.1840120610","volume":"12","author":"GW McCaughan","year":"1990","unstructured":"McCaughan GW, Davies SJ, Waugh JA, Bishop AG, Hall BM, Gallagher ND, Thompson JF, Sheil RAG, Painter DM (1990) A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling. Hepatology 12(6):1305\u20131313. https:\/\/doi.org\/10.1002\/hep.1840120610","journal-title":"Hepatology"},{"issue":"9","key":"12_CR48","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1111\/ajt.16059","volume":"20","author":"M Mengel","year":"2020","unstructured":"Mengel M, Loupy A, Haas M, Roufosse C, Naesens M, Akalin E, Clahsen-van Groningen MC, Dagobert J, Demetris AJ, Duong van Huyen J-P, Gueguen J, Issa F, Robin B, Rosales I, Von der Th\u00fcsen JH, Sanchez-Fueyo A, Smith RN, Wood K, Adam B, Colvin RB (2020) Banff 2019 Meeting Report: molecular diagnostics in solid organ transplantation-Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation. Am J Transplant 20(9):2305\u20132317. https:\/\/doi.org\/10.1111\/ajt.16059","journal-title":"Am J Transplant"},{"issue":"4","key":"12_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/lt.20081","volume":"10","author":"A Miyagawa-Hayashino","year":"2004","unstructured":"Miyagawa-Hayashino A, Tsuruyama T, Haga H, Oike F, Il-Deok K, Egawa H, Hiai H, Tanaka K, Manabe T (2004) Arteriopathy in chronic allograft rejection in liver transplantation. Liver Transpl 10(4):513\u2013519. https:\/\/doi.org\/10.1002\/lt.20081","journal-title":"Liver Transpl"},{"issue":"3","key":"12_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1432-2277.2008.00803.x","volume":"22","author":"A Miyagawa-Hayashino","year":"2009","unstructured":"Miyagawa-Hayashino A, Haga H, Egawa H, Hayashino Y, Uemoto S, Manabe T (2009) Idiopathic post-transplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome. Transpl Int 22(3):303\u2013312. https:\/\/doi.org\/10.1111\/j.1432-2277.2008.00803.x","journal-title":"Transpl Int"},{"issue":"6","key":"12_CR51","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1053\/jhep.2000.20350","volume":"32","author":"Y Nakazawa","year":"2000","unstructured":"Nakazawa Y, Jonsson JR, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, Clouston AD (2000a) Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection. Hepatology 32(6):1240\u20131247. https:\/\/doi.org\/10.1053\/jhep.2000.20350","journal-title":"Hepatology"},{"issue":"8","key":"12_CR52","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/00007890-200004270-00014","volume":"69","author":"Y Nakazawa","year":"2000","unstructured":"Nakazawa Y, Walker NI, Kerlin P, Steadman C, Lynch SV, Strong RW, Clouston AD (2000b) Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients. Transplantation 69(8):1599\u20131608. https:\/\/doi.org\/10.1097\/00007890-200004270-00014","journal-title":"Transplantation"},{"issue":"2","key":"12_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1365-2559.1994.tb01569.x","volume":"25","author":"S Nawaz","year":"1994","unstructured":"Nawaz S, Fennell RH (1994) Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology 25(2):137\u2013142. https:\/\/doi.org\/10.1111\/j.1365-2559.1994.tb01569.x","journal-title":"Histopathology"},{"issue":"3","key":"12_CR54","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1053\/jhep.2002.31726","volume":"35","author":"DAH Neil","year":"2002","unstructured":"Neil DAH, Hubscher SG (2002) Histologic and biochemical changes during the evolution of chronic rejection of liver allografts. Hepatology 35(3):639\u2013651. https:\/\/doi.org\/10.1053\/jhep.2002.31726","journal-title":"Hepatology"},{"issue":"8606","key":"12_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/s0140-6736(88)92356-2","volume":"2","author":"JG O\u2019Grady","year":"1988","unstructured":"O\u2019Grady JG, Alexander GJ, Sutherland S, Donaldson PT, Harvey F, Portmann B, Calne RY, Williams R (1988) Cytomegalovirus infection and donor\/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (London, England) 2(8606):302\u2013305. https:\/\/doi.org\/10.1016\/s0140-6736(88)92356-2","journal-title":"Lancet (London, England)"},{"issue":"2","key":"12_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/lt.23788","volume":"20","author":"JG O\u2019Leary","year":"2014","unstructured":"O\u2019Leary JG, Kaneku H, Demetris AJ, Marr JD, Shiller SM, Susskind BM, Tillery GW, Terasaki PI, Klintmalm GB (2014) Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss. Liver Transpl 20(2):218\u2013227. https:\/\/doi.org\/10.1002\/lt.23788","journal-title":"Liver Transpl"},{"issue":"2","key":"12_CR57","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ajt.13476","volume":"16","author":"JG O\u2019Leary","year":"2016","unstructured":"O\u2019Leary JG, Cai J, Freeman R, Banuelos N, Hart B, Johnson M, Jennings LW, Kaneku H, Terasaki PI, Klintmalm GB, Demetris AJ (2016) Proposed diagnostic criteria for chronic antibody-mediated rejection in liver allografts. Am J Transplant 16(2):603\u2013614. https:\/\/doi.org\/10.1111\/ajt.13476","journal-title":"Am J Transplant"},{"issue":"2","key":"12_CR58","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/hep.1840090207","volume":"9","author":"S Oguma","year":"1989","unstructured":"Oguma S, Belle S, Starzl TE, Demetris AJ (1989a) A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 9(2):204\u2013209. https:\/\/doi.org\/10.1002\/hep.1840090207","journal-title":"Hepatology"},{"issue":"1 Pt 2","key":"12_CR59","first-page":"2203","volume":"21","author":"S Oguma","year":"1989","unstructured":"Oguma S, Zerbe T, Banner B, Belle S, Starzl TE, Demetris AJ (1989b) Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms. Transplant Proc 21(1 Pt 2):2203\u20132207","journal-title":"Transplant Proc"},{"issue":"9","key":"12_CR60","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3390\/bioengineering10091041","volume":"10","author":"MA Rahman","year":"2023","unstructured":"Rahman MA, Yilmaz I, Albadri ST, Salem FE, Dangott BJ, Taner CB, Nassar A, Akkus Z (2023) Artificial intelligence advances in transplant pathology. Bioengineering (Basel, Switzerland) 10(9):1041. https:\/\/doi.org\/10.3390\/bioengineering10091041","journal-title":"Bioengineering (Basel, Switzerland)"},{"issue":"10","key":"12_CR61","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1038\/s41416-023-02213-1","volume":"128","author":"J Ros","year":"2023","unstructured":"Ros J, Salva F, Dopazo C, L\u00f3pez D, Saoudi N, Baraibar I, Charco R, Tabernero J, Elez E (2023) Liver transplantation in metastatic colorectal cancer: are we ready for it? Br J Cancer 128(10):1797\u20131806. https:\/\/doi.org\/10.1038\/s41416-023-02213-1","journal-title":"Br J Cancer"},{"issue":"6","key":"12_CR62","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/TP.0000000000003212","volume":"104","author":"G Sapisochin","year":"2020","unstructured":"Sapisochin G, Javle M, Lerut J, Ohtsuka M, Ghobrial M, Hibi T, Kwan NM, Heimbach J (2020) Liver transplantation for cholangiocarcinoma and mixed hepatocellular cholangiocarcinoma: working group report from the ILTS Transplant Oncology Consensus Conference. Transplantation 104(6):1125\u20131130. https:\/\/doi.org\/10.1097\/TP.0000000000003212","journal-title":"Transplantation"},{"issue":"2","key":"12_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ajt.2024.10.006","volume":"25","author":"N Saravanan","year":"2025","unstructured":"Saravanan N, Demetris A, Fiel MI, Harrington C, Khurram NA, Schiano TD, Levitsky J (2025) Serum and tissue biomarkers of plasma cell-rich rejection in liver transplant recipients. Am J Transplant 25(2):259\u2013268. https:\/\/doi.org\/10.1016\/j.ajt.2024.10.006","journal-title":"Am J Transplant"},{"issue":"6","key":"12_CR64","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4254\/wjh.v13.i6.673","volume":"13","author":"FL Schotters","year":"2021","unstructured":"Schotters FL, Beime J, Briem-Richter A, Binder T, Herden U, Grabhorn EF (2021) Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation. World J Hepatol 13(6):673\u2013685. https:\/\/doi.org\/10.4254\/wjh.v13.i6.673","journal-title":"World J Hepatol"},{"issue":"1","key":"12_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/jhep.2002.30085","volume":"35","author":"M Sebagh","year":"2002","unstructured":"Sebagh M, Blakolmer K, Falissard B, Roche B, Emile JF, Bismuth H, Samuel D, Reyn\u00e8s M (2002) Accuracy of bile duct changes for the diagnosis of chronic liver allograft rejection: reliability of the 1999 Banff schema. Hepatology 35(1):117\u2013125. https:\/\/doi.org\/10.1053\/jhep.2002.30085","journal-title":"Hepatology"},{"issue":"6","key":"12_CR66","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1053\/jhep.2003.50231","volume":"37","author":"M Sebagh","year":"2003","unstructured":"Sebagh M, Rifai K, F\u00e9ray C, Yilmaz F, Falissard B, Roche B, Bismuth H, Samuel D, Reyn\u00e8s M (2003) All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology 37(6):1293\u20131301. https:\/\/doi.org\/10.1053\/jhep.2003.50231","journal-title":"Hepatology"},{"key":"12_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2023.11306","volume":"36","author":"M Sebagh","year":"2023","unstructured":"Sebagh M, Yilmaz F, Kounis I, Saliba F, Feray C, Taupin J-L, Cherqui D, Azoulay D, Samuel D, Coilly A, Demetris A-J, Neil D (2023) Evidence for alloimmune sinusoidal injury in de novo nodular regenerative hyperplasia after liver transplantation. Transpl Int 36:11306. https:\/\/doi.org\/10.3389\/ti.2023.11306","journal-title":"Transpl Int"},{"issue":"7","key":"12_CR68","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/lt.21060","volume":"13","author":"M Seyam","year":"2007","unstructured":"Seyam M, Neuberger JM, Gunson BK, H\u00fcbscher SG (2007) Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence. Liver Transpl 13(7):966\u2013974. https:\/\/doi.org\/10.1002\/lt.21060","journal-title":"Liver Transpl"},{"issue":"1\u20132","key":"12_CR69","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/s0041-1345(00)02826-8","volume":"33","author":"M Spada","year":"2001","unstructured":"Spada M, Bertani A, Sonzogni A, Petz W, Riva S, Torre G, Melzi ML, Alberti D, Colledan M, Segalin A, Lucianetti A, Gridelli B (2001) A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. Transplant Proc 33(1\u20132):1747\u20131748. https:\/\/doi.org\/10.1016\/s0041-1345(00)02826-8","journal-title":"Transplant Proc"},{"issue":"6","key":"12_CR70","first-page":"412","volume":"25","author":"H Tariq","year":"2015","unstructured":"Tariq H, Nasir H (2015) Spectrum of histopathological findings in live donor liver graft biopsies. J Coll Physicians Surg Pak 25(6):412\u2013416","journal-title":"J Coll Physicians Surg Pak"},{"issue":"11","key":"12_CR71","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1111\/j.1600-6143.2012.04210.x","volume":"12","author":"C Venturi","year":"2012","unstructured":"Venturi C, Sempoux C, Bueno J, Ferreres Pinas JC, Bourdeaux C, Abarca-Quinones J, Rahier J, Reding R (2012) Novel histologic scoring system for long-term allograft fibrosis after liver transplantation in children. Am J Transplant 12(11):2986\u20132996. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04210.x","journal-title":"Am J Transplant"},{"issue":"4","key":"12_CR72","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/JTLS005s00001","volume":"5","author":"JM Vierling","year":"1999","unstructured":"Vierling JM (1999) Immunology of acute and chronic hepatic allograft rejection. Liver Transpl Surg 5(4):S1\u2013S20. https:\/\/doi.org\/10.1053\/JTLS005s00001","journal-title":"Liver Transpl Surg"},{"issue":"7","key":"12_CR73","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/21548331.1990.11703976","volume":"25","author":"JM Vierling","year":"1990","unstructured":"Vierling JM, Howell CD (1990) Disappearing bile ducts: immunologic mechanisms. Hosp Pract (Off Ed) 25(7):141\u2013150. https:\/\/doi.org\/10.1080\/21548331.1990.11703976","journal-title":"Hosp Pract (Off Ed)"},{"issue":"6","key":"12_CR74","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.jhep.2021.08.007","volume":"75","author":"J Vionnet","year":"2021","unstructured":"Vionnet J, Miquel R, Abraldes JG, Wall J, Kodela E, Lozano J-J, Ruiz P, Navasa M, Marshall A, Nevens F, Gelson W, Leithead J, Masson S, Jaeckel E, Taubert R, Tachtatzis P, Eurich D, Simpson KJ, Bonaccorsi-Riani E et al (2021) Non-invasive alloimmune risk stratification of long-term liver transplant recipients. J Hepatol 75(6):1409\u20131419. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.007","journal-title":"J Hepatol"},{"issue":"12","key":"12_CR75","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/lt.21949","volume":"15","author":"SC Ward","year":"2009","unstructured":"Ward SC, Schiano TD, Thung SN, Fiel MI (2009) Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl 15(12):1826\u20131833. https:\/\/doi.org\/10.1002\/lt.21949","journal-title":"Liver Transpl"},{"issue":"4 Pt 1","key":"12_CR76","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0270-9139(91)90064-3","volume":"14","author":"RH Wiesner","year":"1991","unstructured":"Wiesner RH, Ludwig J, van Hoek B, Krom RA (1991) Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 14(4 Pt 1):721\u2013729. https:\/\/doi.org\/10.1016\/0270-9139(91)90064-3","journal-title":"Hepatology"},{"issue":"1","key":"12_CR77","first-page":"465","volume":"28","author":"DA Wight","year":"1996","unstructured":"Wight DA (1996) Chronic liver transplant rejection: definition and diagnosis. Transplant Proc 28(1):465\u2013467","journal-title":"Transplant Proc"},{"issue":"7","key":"12_CR78","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/TP.0000000000000796","volume":"99","author":"LJ Wozniak","year":"2015","unstructured":"Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid SV, Reed EF (2015) Donor-specific HLA antibodies are associated with late allograft dysfunction after pediatric liver transplantation. Transplantation 99(7):1416\u20131422. https:\/\/doi.org\/10.1097\/TP.0000000000000796","journal-title":"Transplantation"},{"issue":"10","key":"12_CR79","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1097\/TP.0000000000001851","volume":"101","author":"Z Yi","year":"2017","unstructured":"Yi Z, Mayorga ME, Orman ES, Wheeler SB, Hayashi PH, Barritt AS (2017) Trends in characteristics of patients listed for liver transplantation will lead to higher rates of waitlist removal due to clinical deterioration. Transplantation 101(10):2368\u20132374. https:\/\/doi.org\/10.1097\/TP.0000000000001851","journal-title":"Transplantation"},{"issue":"5","key":"12_CR80","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.transproceed.2006.02.108","volume":"38","author":"F Yilmaz","year":"2006","unstructured":"Yilmaz F, Aydin U, Nart D, Zeytunlu M, Karasu Z, Kaya T, Ozer I, Yuce G, Aydogdu S, Kilic M (2006) The incidence and management of acute and chronic rejection after living donor liver transplantation. Transplant Proc 38(5):1435\u20131437. https:\/\/doi.org\/10.1016\/j.transproceed.2006.02.108","journal-title":"Transplant Proc"},{"issue":"1","key":"12_CR81","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000352","volume":"8","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Stepanova M, Al Shabeeb R, Eberly KE, Shah D, Nguyen V, Ong J, Henry L, Alqahtani SA (2024) The changing epidemiology of adult liver transplantation in the United States in 2013\u20132022: the dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. Hepatol Commun 8(1):e0352. https:\/\/doi.org\/10.1097\/HC9.0000000000000352","journal-title":"Hepatol Commun"},{"issue":"7","key":"12_CR82","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nrgastro.2013.88","volume":"10","author":"A Zarrinpar","year":"2013","unstructured":"Zarrinpar A, Busuttil RW (2013) Liver transplantation: past, present and future. Nat Rev Gastroenterol Hepatol 10(7):434\u2013440. https:\/\/doi.org\/10.1038\/nrgastro.2013.88","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Results and Problems in Cell Differentiation","Cellular and Molecular Mechanisms of Chronic Rejection in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-07686-1_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T23:38:41Z","timestamp":1767310721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-07686-1_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032076854","9783032076861"],"references-count":82,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-07686-1_12","relation":{},"ISSN":["0080-1844","1861-0412"],"issn-type":[{"value":"0080-1844","type":"print"},{"value":"1861-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 January 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}